Delivery Order SPE2DB22D3016-SPE2DB24FAUB2
Award Date
4/30/24
Potential Completion Date
5/1/24
Potential Value
$3.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,665.78, is for the delivery of Dapagliflozin 10 mg tablets. The contract has a completion date of August 27, 2024 and is a firm fixed-price contract. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,274.86 firm fixed-price contract is for the delivery of 4,565,614,775 Dapagliflozin 10 mg tablets. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,941,013 units of Dapagliflozin 10 mg tablets, a prescription medication. The order has a ceiling value of $3,969.09 and a completion date of September 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order under a larger Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,406.23 firm fixed-price contract is for the supply of 4,565,693,581 units of the pharmaceutical product dapagliflozin 10 mg tablets. The award has an ultimate completion date of September 6, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) worth up to $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4,565,468,045 units of the pharmaceutical product Dapagliflozin 10 mg Tablets. The contract has a ceiling value of $13,780.10 and an ultimate completion date of August 16, 2024. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of dapagliflozin 10 mg tablets. The delivery order, valued at $4,087.64, is a firm fixed-price contract with a completion date of May 6, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems. The...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, is for the delivery of 4,564,755,292 units of Dapagliflozin 10 mg tablets. The contract, valued at $16,574.98, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,067.27, is for the delivery of dapagliflozin 10 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This federal contract award from the Defense Logistics Agency (DLA) is a $2,116.01 firm fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,566,627,303 units of the prescription drug Dapagliflozin 10 mg tablets, which are used to treat type 2 diabetes. The contract has an ultimate completion date of December 6, 2024 and was awarded on December 5, 2024. AmerisourceBergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides delivery of Dapagliflozin 10mg tablets worth $5,880.86. The contract is a Firm Fixed Price Delivery Order placed by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 7, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...